<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34770987</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>03</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1420-3049</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>21</Issue><PubDate><Year>2021</Year><Month>Oct</Month><Day>30</Day></PubDate></JournalIssue><Title>Molecules (Basel, Switzerland)</Title><ISOAbbreviation>Molecules</ISOAbbreviation></Journal><ArticleTitle>Molecular Docking of SP40 Peptide towards Cellular Receptors for Enterovirus 71 (EV-A71).</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">6576</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/molecules26216576</ELocationID><Abstract><AbstractText>Enterovirus 71 (EV-A71) is one of the predominant etiological agents of hand, foot and mouth disease (HMFD), which can cause severe central nervous system infections in young children. There is no clinically approved vaccine or antiviral agent against HFMD. The SP40 peptide, derived from the VP1 capsid of EV-A71, was reported to be a promising antiviral peptide that targeted the host receptor(s) involved in viral attachment or entry. So far, the mechanism of action of SP40 peptide is unknown. In this study, interactions between ten reported cell receptors of EV-A71 and the antiviral SP40 peptide were evaluated through molecular docking simulations, followed by in vitro receptor blocking with specific antibodies. The preferable binding region of each receptor to SP40 was predicted by global docking using HPEPDOCK and the cell receptor-SP40 peptide complexes were refined using FlexPepDock. Local molecular docking using GOLD (Genetic Optimization for Ligand Docking) showed that the SP40 peptide had the highest binding score to nucleolin followed by annexin A2, SCARB2 and human tryptophanyl-tRNA synthetase. The average GoldScore for 5 top-scoring models of human cyclophilin, fibronectin, human galectin, DC-SIGN and vimentin were almost similar. Analysis of the nucleolin-SP40 peptide complex showed that SP40 peptide binds to the RNA binding domains (RBDs) of nucleolin. Furthermore, receptor blocking by specific monoclonal antibody was performed for seven cell receptors of EV-A71 and the results showed that the blocking of nucleolin by anti-nucleolin alone conferred a 93% reduction in viral infectivity. Maximum viral inhibition (99.5%) occurred when SCARB2 was concurrently blocked with anti-SCARB2 and the SP40 peptide. This is the first report to reveal the mechanism of action of SP40 peptide in silico through molecular docking analysis. This study provides information on the possible binding site of SP40 peptide to EV-A71 cellular receptors. Such information could be useful to further validate the interaction of the SP40 peptide with nucleolin by site-directed mutagenesis of the nucleolin binding site.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Masomian</LastName><ForeName>Malihe</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centre of Virus and Vaccine Research, School of Medical and Life Science, Sunway University, Bandar Sunway, Petaling Jaya 47500, Selangor, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lalani</LastName><ForeName>Salima</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Centre of Virus and Vaccine Research, School of Medical and Life Science, Sunway University, Bandar Sunway, Petaling Jaya 47500, Selangor, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poh</LastName><ForeName>Chit Laa</ForeName><Initials>CL</Initials><Identifier Source="ORCID">0000-0001-8475-6291</Identifier><AffiliationInfo><Affiliation>Centre of Virus and Vaccine Research, School of Medical and Life Science, Sunway University, Bandar Sunway, Petaling Jaya 47500, Selangor, Malaysia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>GRTIN-IRG-24-2021</GrantID><Agency>Sunway University Individual Research Grant 2021</Agency><Country/></Grant><Grant><GrantID>FRGS/1/2018/SKK11/SYUC/03/3</GrantID><Agency>FRGS Grant</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>10</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Molecules</MedlineTA><NlmUniqueID>100964009</NlmUniqueID><ISSNLinking>1420-3049</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010455">Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011956">Receptors, Cell Surface</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000138" MajorTopicYN="N">chemical synthesis</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062105" MajorTopicYN="Y">Molecular Docking Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010455" MajorTopicYN="N">Peptides</DescriptorName><QualifierName UI="Q000138" MajorTopicYN="N">chemical synthesis</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011956" MajorTopicYN="N">Receptors, Cell Surface</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012984" MajorTopicYN="N">Software</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SCARB2</Keyword><Keyword MajorTopicYN="N">annexin2</Keyword><Keyword MajorTopicYN="N">hand, foot and mouth disease</Keyword><Keyword MajorTopicYN="N">human tryptophanyl-tRNA synthetase</Keyword><Keyword MajorTopicYN="N">molecular docking</Keyword><Keyword MajorTopicYN="N">nucleolin</Keyword><Keyword MajorTopicYN="N">receptor blocking</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>7</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>10</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>10</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>13</Day><Hour>1</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>10</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34770987</ArticleId><ArticleId IdType="pmc">PMC8587434</ArticleId><ArticleId IdType="doi">10.3390/molecules26216576</ArticleId><ArticleId IdType="pii">molecules26216576</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Repass G.L., Palmer W.C., Stancampiano F.F. Hand, foot, and mouth disease: Identifying and managing an acute viral syndrome. Clevel. Clin. J. Med. 2014;81:537&#x2013;543. doi: 10.3949/ccjm.81a.13132.</Citation><ArticleIdList><ArticleId IdType="doi">10.3949/ccjm.81a.13132</ArticleId><ArticleId IdType="pubmed">25183845</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein M., Chong P. Is a multivalent hand, foot, and mouth disease vaccine feasible? Hum. Vaccin. Immunother. 2015;11:2688&#x2013;2704. doi: 10.1080/21645515.2015.1049780.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2015.1049780</ArticleId><ArticleId IdType="pmc">PMC4685682</ArticleId><ArticleId IdType="pubmed">26009802</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho M., Chen E.R., Hsu K.H., Twu S.J., Chen K.T., Tsai S.F., Wang J.R., Shih S.R. An epidemic of enterovirus 71 infection in Taiwan: Taiwan enterovirus epidemic working group. N. Engl. J. Med. 1999;341:929&#x2013;935. doi: 10.1056/NEJM199909233411301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199909233411301</ArticleId><ArticleId IdType="pubmed">10498487</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan L.G., Parashar U.D., Lye M.S., Ong F.G., Zaki S.R., Alexander J.P., Ho K.K., Han L.L., Pallansch M.A., Suleiman A.B., et al. Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: Clinical and pathological characteristics of the disease. For the Outbreak Study Group. Clin. Infect. Dis. 2000;31:678&#x2013;683. doi: 10.1086/314032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/314032</ArticleId><ArticleId IdType="pubmed">11017815</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang F., Ren L., Xiong Z., Li J., Xiao Y., Zhao R., He Y., Bu G., Zhou S., Wang J., et al. Enterovirus 71 outbreak in the People&#x2019;s Republic of China in 2008. J. Clin. Microbiol. 2009;47:2351&#x2013;2352. doi: 10.1128/JCM.00563-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00563-09</ArticleId><ArticleId IdType="pmc">PMC2708525</ArticleId><ArticleId IdType="pubmed">19439545</ArticleId></ArticleIdList></Reference><Reference><Citation>Ventarola D., Bordone L., Silverberg N. Update on hand-foot-and-mouth disease. Clin. Dermatol. 2015;33:340&#x2013;346. doi: 10.1016/j.clindermatol.2014.12.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clindermatol.2014.12.011</ArticleId><ArticleId IdType="pubmed">25889136</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong S.S., Yip C.C., Lau S.K., Yuen K.Y. Human enterovirus 71 and hand, foot and mouth disease. Epidemiol. Infect. 2010;138:1071&#x2013;1089. doi: 10.1017/S0950268809991555.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268809991555</ArticleId><ArticleId IdType="pubmed">20056019</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. WHO Regional Office for the Western Pacific . Hand, Foot and Mouth Disease Situation Update 2018. WHO Regional Office for the Western Pacific; Manila, Philippines: 2018.</Citation></Reference><Reference><Citation>Lu Q.-B., Zhang X.-A., Wo Y., Xu H.-M., Li X.-J., Wang X.-J., Ding S.-J., Chen X.-D., He C., Liu L.-J., et al. Circulation of coxsackievirus A10 and A6 in hand-foot-mouth disease in China, 2009&#x2013;011. PLoS ONE. 2012;7:e52073. doi: 10.1371/journal.pone.0052073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0052073</ArticleId><ArticleId IdType="pmc">PMC3525556</ArticleId><ArticleId IdType="pubmed">23272213</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang F., Yuan J., Wang X., Li J., Du J., Su H., Zhou B., Jin Q. Severe hand, foot, and mouth disease and coxsackievirus A6- Shenzhen, China. Clin. Infect. Dis. 2014;59:1504&#x2013;1505. doi: 10.1093/cid/ciu624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciu624</ArticleId><ArticleId IdType="pubmed">25091307</ArticleId></ArticleIdList></Reference><Reference><Citation>Puenpa J., Auphimai C., Korkong S., Vongpunsawad S., Poovorawan Y. Enterovirus A71 Infection, Thailand, 2017. Emerg. Infect. Dis. 2018;24:1386&#x2013;1387. doi: 10.3201/eid2407.171923.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2407.171923</ArticleId><ArticleId IdType="pmc">PMC6038748</ArticleId><ArticleId IdType="pubmed">29912701</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi E., Shin Y., Kim J., Kim T., Chang S. Enterovirus 71 infection and vaccines. Clin. Exp. Vaccine Res. 2017;6:4&#x2013;14. doi: 10.7774/cevr.2017.6.1.4.</Citation><ArticleIdList><ArticleId IdType="doi">10.7774/cevr.2017.6.1.4</ArticleId><ArticleId IdType="pmc">PMC5292356</ArticleId><ArticleId IdType="pubmed">28168168</ArticleId></ArticleIdList></Reference><Reference><Citation>Aswathyraj S., Arunkumar G., Alidjinou E.K., Hober D. Hand, foot and mouth disease (HFMD): Emerging epidemiology and the need for a vaccine strategy. Med. Microbiol. Immunol. 2016;205:397&#x2013;407. doi: 10.1007/s00430-016-0465-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00430-016-0465-y</ArticleId><ArticleId IdType="pubmed">27406374</ArticleId></ArticleIdList></Reference><Reference><Citation>De Clercq E., Li G. Approved antiviral drugs over the past 50 years. Clin. Microbiol. Rev. 2016;29:695&#x2013;747. doi: 10.1128/CMR.00102-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00102-15</ArticleId><ArticleId IdType="pmc">PMC4978613</ArticleId><ArticleId IdType="pubmed">27281742</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee A.C.-L., Harris J.L., Khanna K.K., Hong J.-H. A Comprehensive Review on Current Advances in Peptide Drug Development and Design. Int. J. Mol. Sci. 2019;20:2383. doi: 10.3390/ijms20102383.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20102383</ArticleId><ArticleId IdType="pmc">PMC6566176</ArticleId><ArticleId IdType="pubmed">31091705</ArticleId></ArticleIdList></Reference><Reference><Citation>Chew M.-F., Poh K.-S., Poh C.-L. Peptides as Therapeutic Agents for Dengue Virus. Int. J. Med. Sci. 2017;14:1342&#x2013;1359. doi: 10.7150/ijms.21875.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijms.21875</ArticleId><ArticleId IdType="pmc">PMC5707751</ArticleId><ArticleId IdType="pubmed">29200948</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S., Yamashita Y., Li J., Hanagata N., Minowa T., Takemura T., Koike S. Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat. Med. 2009;15:798&#x2013;801. doi: 10.1038/nm.1992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.1992</ArticleId><ArticleId IdType="pubmed">19543282</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y., Shimojima M., Tano Y., Miyamura T., Wakita T., Shimizu H. Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat. Med. 2009;15:794. doi: 10.1038/nm.1961.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.1961</ArticleId><ArticleId IdType="pubmed">19543284</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan C.W., Poh C.L., Sam I.C., Chan Y.F. Enterovirus 71 uses cell surface heparan sulfate glycosaminoglycan as an attachment receptor. J. Virol. 2013;87:611&#x2013;620. doi: 10.1128/JVI.02226-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02226-12</ArticleId><ArticleId IdType="pmc">PMC3536405</ArticleId><ArticleId IdType="pubmed">23097443</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang S.-L., Chou Y.-T., Wu C.-N., Ho M.-S. Annexin II binds to capsid protein VP1 of enterovirus 71 and enhances viral infectivity. J. Virol. 2011;85:11809&#x2013;11820. doi: 10.1128/JVI.00297-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00297-11</ArticleId><ArticleId IdType="pmc">PMC3209289</ArticleId><ArticleId IdType="pubmed">21900167</ArticleId></ArticleIdList></Reference><Reference><Citation>Su P.-Y., Wang Y.-F., Huang S.-W., Lo Y.-C., Wang Y.-H., Wu S.-R., Shieh D.-B., Chen S.-H., Wang J.-R., Lai M.-D. Cell surface nucleolin facilitates enterovirus 71 binding and infection. J. Virol. 2015;89:4527&#x2013;4538. doi: 10.1128/JVI.03498-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03498-14</ArticleId><ArticleId IdType="pmc">PMC4442404</ArticleId><ArticleId IdType="pubmed">25673703</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren X.-X., Ma L., Liu Q.-W., Li C., Huang Z., Wu L., Xiong S.-D., Wang J.-H., Wang H.-B. The molecule of DC-SIGN captures enterovirus 71 and confers dendritic cell-mediated viral trans-infection. Virol. J. 2014;11:47. doi: 10.1186/1743-422X-11-47.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-11-47</ArticleId><ArticleId IdType="pmc">PMC3995660</ArticleId><ArticleId IdType="pubmed">24620896</ArticleId></ArticleIdList></Reference><Reference><Citation>He Q.-Q., Ren S., Xia Z.-C., Cheng Z.-K., Peng N.-F., Zhu Y. Fibronectin Facilitates Enterovirus 71 Infection by Mediating Viral Entry. J. Virol. 2018;92:e02251-17. doi: 10.1128/JVI.02251-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02251-17</ArticleId><ArticleId IdType="pmc">PMC5899198</ArticleId><ArticleId IdType="pubmed">29467312</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeung M.L., Jia L., Yip C.C.Y., Chan J.F.W., Teng J.L.L., Chan K.H., Cai J.P., Zhang C., Zhang A.J., Wong W.M., et al. Human tryptophanyl-tRNA synthetase is an IFN-&#x3b3;-inducible entry factor for Enterovirus. J. Clin. Investig. 2018;128:5163&#x2013;5177. doi: 10.1172/JCI99411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI99411</ArticleId><ArticleId IdType="pmc">PMC6205371</ArticleId><ArticleId IdType="pubmed">30153112</ArticleId></ArticleIdList></Reference><Reference><Citation>Du N., Cong H., Tian H., Zhang H., Zhang W., Song L., Tien P. Cell surface vimentin is an attachment receptor for enterovirus 71. J. Virol. 2014;88:5816&#x2013;5833. doi: 10.1128/JVI.03826-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03826-13</ArticleId><ArticleId IdType="pmc">PMC4019121</ArticleId><ArticleId IdType="pubmed">24623428</ArticleId></ArticleIdList></Reference><Reference><Citation>Too I.H.K., Bonne I., Tan E.L., Chu J.J.H., Alonso S. Prohibitin plays a critical role in Enterovirus 71 neuropathogenesis. PLoS Pathog. 2018;14:e1006778. doi: 10.1371/journal.ppat.1006778.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006778</ArticleId><ArticleId IdType="pmc">PMC5764453</ArticleId><ArticleId IdType="pubmed">29324904</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee P.-H., Liu C.-M., Ho T.-S., Tsai Y.-C., Lin C.-C., Wang Y.-F., Chen Y.-L., Yu C.-K., Wang S.-M., Liu C.-C., et al. Enterovirus 71 virion-associated galectin-1 facilitates viral replication and stability. PLoS ONE. 2015;10:e0116278. doi: 10.1371/journal.pone.0116278.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0116278</ArticleId><ArticleId IdType="pmc">PMC4338065</ArticleId><ArticleId IdType="pubmed">25706563</ArticleId></ArticleIdList></Reference><Reference><Citation>Qing J., Wang Y., Sun Y., Huang J., Yan W., Wang J., Su D., Ni C., Li J., Rao Z., et al. Cyclophilin A Associates with Enterovirus-71 Virus Capsid and Plays an Essential Role in Viral Infection as an Uncoating Regulator. PLoS Pathog. 2014;10:e1004422. doi: 10.1371/journal.ppat.1004422.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1004422</ArticleId><ArticleId IdType="pmc">PMC4183573</ArticleId><ArticleId IdType="pubmed">25275585</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander D.A., Dimock K. Sialic acid functions in enterovirus 70 binding and infection. J. Virol. 2002;76:11265&#x2013;11272. doi: 10.1128/JVI.76.22.11265-11272.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.76.22.11265-11272.2002</ArticleId><ArticleId IdType="pmc">PMC136758</ArticleId><ArticleId IdType="pubmed">12388686</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi K., Koike S. Cellular receptors for enterovirus A71. J. Biomed. Sci. 2020;27:23. doi: 10.1186/s12929-020-0615-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-020-0615-9</ArticleId><ArticleId IdType="pmc">PMC6954530</ArticleId><ArticleId IdType="pubmed">31924205</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan C.W., Chan Y.F., Sim K.M., Tan E.L., Poh C.L. Inhibition of Enterovirus 71 (EV-71) Infections by a Novel Antiviral Peptide Derived from EV-71 Capsid Protein VP1. PLoS ONE. 2012;7:e34589. doi: 10.1371/journal.pone.0034589.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0034589</ArticleId><ArticleId IdType="pmc">PMC3341398</ArticleId><ArticleId IdType="pubmed">22563456</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciemny M., Kurcinski M., Kamel K., Kolinski A., Alam N., Schueler-Furman O., Kmiecik S. Protein&#x2013;peptide docking: Opportunities and challenges. Drug Discov. Today. 2018;23:1530&#x2013;1537. doi: 10.1016/j.drudis.2018.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.drudis.2018.05.006</ArticleId><ArticleId IdType="pubmed">29733895</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H., Heo L., Lee M.S., Seok C. GalaxyPepDock: A protein&#x2013;peptide docking tool based on interaction similarity and energy optimization. Nucleic Acids Res. 2015;43:W431&#x2013;W435. doi: 10.1093/nar/gkv495.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkv495</ArticleId><ArticleId IdType="pmc">PMC4489314</ArticleId><ArticleId IdType="pubmed">25969449</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan C., Xu X., Zou X. Fully Blind Docking at the Atomic Level for Protein-Peptide Complex Structure Prediction. Structure. 2016;24:1842&#x2013;1853. doi: 10.1016/j.str.2016.07.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.str.2016.07.021</ArticleId><ArticleId IdType="pmc">PMC5080282</ArticleId><ArticleId IdType="pubmed">27642160</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou P., Jin B., Li H., Huang S.-Y. HPEPDOCK: A web server for blind peptide-protein docking based on a hierarchical algorithm. Nucleic Acids Res. 2018;46:W443&#x2013;W450. doi: 10.1093/nar/gky357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky357</ArticleId><ArticleId IdType="pmc">PMC6030929</ArticleId><ArticleId IdType="pubmed">29746661</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurcinski M., Jamroz M., Blaszczyk M., Kolinski A., Kmiecik S. CABS-dock web server for the flexible docking of peptides to proteins without prior knowledge of the binding site. Nucleic Acids Res. 2015;43:W419&#x2013;W424. doi: 10.1093/nar/gkv456.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkv456</ArticleId><ArticleId IdType="pmc">PMC4489223</ArticleId><ArticleId IdType="pubmed">25943545</ArticleId></ArticleIdList></Reference><Reference><Citation>Schindler C.E.M., de Vries S.J., Zacharias M. Fully Blind Peptide-Protein Docking with pepATTRACT. Structure. 2015;23:1507&#x2013;1515. doi: 10.1016/j.str.2015.05.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.str.2015.05.021</ArticleId><ArticleId IdType="pubmed">26146186</ArticleId></ArticleIdList></Reference><Reference><Citation>Antunes D.A., Moll M., Devaurs D., Jackson K.R., Liz&#xe9;e G., Kavraki L.E. DINC 2.0: A New Protein&#x2013;Peptide Docking Webserver Using an Incremental Approach. Cancer Res. 2017;77:e55. doi: 10.1158/0008-5472.CAN-17-0511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-17-0511</ArticleId><ArticleId IdType="pmc">PMC5679007</ArticleId><ArticleId IdType="pubmed">29092940</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Sanner M.F. AutoDock CrankPep: Combining folding and docking to predict protein&#x2013;peptide complexes. Bioinformatics. 2019;35:5121&#x2013;5127. doi: 10.1093/bioinformatics/btz459.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btz459</ArticleId><ArticleId IdType="pmc">PMC6954657</ArticleId><ArticleId IdType="pubmed">31161213</ArticleId></ArticleIdList></Reference><Reference><Citation>Trellet M., Melquiond A.S.J., Bonvin A.M.J.J. A Unified Conformational Selection and Induced Fit Approach to Protein-Peptide Docking. PLoS ONE. 2013;8:e58769. doi: 10.1371/journal.pone.0058769.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0058769</ArticleId><ArticleId IdType="pmc">PMC3596317</ArticleId><ArticleId IdType="pubmed">23516555</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones G., Willett P., Glen R.C., Leach A.R., Taylor R. Development and validation of a genetic algorithm for flexible docking11Edited by F. E. Cohen. J. Mol. Biol. 1997;267:727&#x2013;748. doi: 10.1006/jmbi.1996.0897.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jmbi.1996.0897</ArticleId><ArticleId IdType="pubmed">9126849</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng G., Gao J., Wang Z., Wang E., Hu X., Yao X., Cao D., Hou T. Comprehensive Evaluation of Fourteen Docking Programs on Protein-Peptide Complexes. J. Chem. Theory Comput. 2020;16:3959&#x2013;3969. doi: 10.1021/acs.jctc.9b01208.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jctc.9b01208</ArticleId><ArticleId IdType="pubmed">32324992</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan Y., Zhang D., Huang S.Y. Efficient conformational ensemble generation of protein-bound peptides. J. Cheminform. 2017;9:59. doi: 10.1186/s13321-017-0246-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13321-017-0246-7</ArticleId><ArticleId IdType="pmc">PMC5700017</ArticleId><ArticleId IdType="pubmed">29168051</ArticleId></ArticleIdList></Reference><Reference><Citation>De Vries S.J., Rey J., Schindler C.E.M., Zacharias M., Tuffery P. The pepATTRACT web server for blind, large-scale peptide-protein docking. Nucleic Acids Res. 2017;45:W361&#x2013;W364. doi: 10.1093/nar/gkx335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkx335</ArticleId><ArticleId IdType="pmc">PMC5570166</ArticleId><ArticleId IdType="pubmed">28460116</ArticleId></ArticleIdList></Reference><Reference><Citation>London N., Raveh B., Cohen E., Fathi G., Schueler-Furman O. Rosetta FlexPepDock web server--high resolution modeling of peptide-protein interactions. Nucleic Acids Res. 2011;39:W249&#x2013;W253. doi: 10.1093/nar/gkr431.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkr431</ArticleId><ArticleId IdType="pmc">PMC3125795</ArticleId><ArticleId IdType="pubmed">21622962</ArticleId></ArticleIdList></Reference><Reference><Citation>Lomize A.L., Pogozheva I. Modeling of Peptide Folding and Translocation across Membranes. Biophys. J. 2018;114:267a. doi: 10.1016/j.bpj.2017.11.1545.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpj.2017.11.1545</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Izumi R.E., Valdez B., Banerjee R., Srivastava M., Dasgupta A. Nucleolin stimulates viral internal ribosome entry site-mediated translation. Virus Res. 2001;76:17&#x2013;29. doi: 10.1016/S0168-1702(01)00240-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0168-1702(01)00240-4</ArticleId><ArticleId IdType="pubmed">11376843</ArticleId></ArticleIdList></Reference><Reference><Citation>De Verdugo U.R., Selinka H.C., Huber M., Kramer B., Kellermann J., Hofschneider P.H., Kandolf R. Characterization of a 100-kilodalton binding protein for the six serotypes of coxsackie B viruses. J. Virol. 1995;69:6751&#x2013;6757. doi: 10.1128/jvi.69.11.6751-6757.1995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.69.11.6751-6757.1995</ArticleId><ArticleId IdType="pmc">PMC189586</ArticleId><ArticleId IdType="pubmed">7474086</ArticleId></ArticleIdList></Reference><Reference><Citation>Tajrishi M.M., Tuteja R., Tuteja N. Nucleolin: The most abundant multifunctional phosphoprotein of nucleolus. Commun. Integr. Biol. 2011;4:267&#x2013;275. doi: 10.4161/cib.4.3.14884.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/cib.4.3.14884</ArticleId><ArticleId IdType="pmc">PMC3187884</ArticleId><ArticleId IdType="pubmed">21980556</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Farmer J.D., Jr., Lane W.S., Friedman J., Weissman I., Schreiber S.L. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell. 1991;66:807&#x2013;815. doi: 10.1016/0092-8674(91)90124-H.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(91)90124-H</ArticleId><ArticleId IdType="pubmed">1715244</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou D., Mei Q., Li J., He H. Cyclophilin A and viral infections. Biochem. Biophys. Res. Commun. 2012;424:647&#x2013;650. doi: 10.1016/j.bbrc.2012.07.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2012.07.024</ArticleId><ArticleId IdType="pmc">PMC7092870</ArticleId><ArticleId IdType="pubmed">22814107</ArticleId></ArticleIdList></Reference><Reference><Citation>Clubb R.T., Ferguson S.B., Walsh C.T., Wagner G. Three-dimensional solution structure of Escherichia coli periplasmic cyclophilin. Biochemistry. 1994;33:2761&#x2013;2772. doi: 10.1021/bi00176a004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi00176a004</ArticleId><ArticleId IdType="pubmed">8130188</ArticleId></ArticleIdList></Reference><Reference><Citation>Leffler H., Carlsson S., Hedlund M., Qian Y., Poirier F. Introduction to galectins. Glycoconj. J. 2002;19:433&#x2013;440. doi: 10.1023/B:GLYC.0000014072.34840.04.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/B:GLYC.0000014072.34840.04</ArticleId><ArticleId IdType="pubmed">14758066</ArticleId></ArticleIdList></Reference><Reference><Citation>Camby I., Le Mercier M., Lefranc F., Kiss R. Galectin-1: A small protein with major functions. Glycobiology. 2006;16:137r&#x2013;157r. doi: 10.1093/glycob/cwl025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/glycob/cwl025</ArticleId><ArticleId IdType="pubmed">16840800</ArticleId></ArticleIdList></Reference><Reference><Citation>Bao J., Wang X., Liu S., Zou Q., Zheng S., Yu F., Chen Y. Galectin-1 Ameliorates Influenza A H1N1pdm09 Virus-Induced Acute Lung Injury. Front. Microbiol. 2020;11:1293. doi: 10.3389/fmicb.2020.01293.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.01293</ArticleId><ArticleId IdType="pmc">PMC7303544</ArticleId><ArticleId IdType="pubmed">32595629</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Lucendo M.F., Sol&#xed;s D., Andr&#xe9; S., Hirabayashi J., Kasai K., Kaltner H., Gabius H.J., Romero A. Growth-regulatory human galectin-1: Crystallographic characterisation of the structural changes induced by single-site mutations and their impact on the thermodynamics of ligand binding. J. Mol. Biol. 2004;343:957&#x2013;970. doi: 10.1016/j.jmb.2004.08.078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2004.08.078</ArticleId><ArticleId IdType="pubmed">15476813</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh P., Carraher C., Schwarzbauer J.E. Assembly of fibronectin extracellular matrix. Annu. Rev. Cell Dev. Biol. 2010;26:397&#x2013;419. doi: 10.1146/annurev-cellbio-100109-104020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-cellbio-100109-104020</ArticleId><ArticleId IdType="pmc">PMC3628685</ArticleId><ArticleId IdType="pubmed">20690820</ArticleId></ArticleIdList></Reference><Reference><Citation>Eskelinen E.L., Tanaka Y., Saftig P. At the acidic edge: Emerging functions for lysosomal membrane proteins. Trends Cell Biol. 2003;13:137&#x2013;145. doi: 10.1016/S0962-8924(03)00005-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0962-8924(03)00005-9</ArticleId><ArticleId IdType="pubmed">12628346</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou D., Zhao Y., Kotecha A., Fry E.E., Kelly J.T., Wang X., Rao Z., Rowlands D.J., Ren J., Stuart D.I. Unexpected mode of engagement between enterovirus 71 and its receptor SCARB2. Nat. Microbiol. 2019;4:414&#x2013;419. doi: 10.1038/s41564-018-0319-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-018-0319-z</ArticleId><ArticleId IdType="pubmed">30531980</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S., Ohka S., Fujii K., Koike S. Functional comparison of SCARB2 and PSGL1 as receptors for enterovirus 71. J. Virol. 2013;87:3335&#x2013;3347. doi: 10.1128/JVI.02070-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02070-12</ArticleId><ArticleId IdType="pmc">PMC3592140</ArticleId><ArticleId IdType="pubmed">23302872</ArticleId></ArticleIdList></Reference><Reference><Citation>Geijtenbeek T.B., Torensma R., van Vliet S.J., van Duijnhoven G.C., Adema G.J., van Kooyk Y., Figdor C.G. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell. 2000;100:575&#x2013;585. doi: 10.1016/S0092-8674(00)80693-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(00)80693-5</ArticleId><ArticleId IdType="pubmed">10721994</ArticleId></ArticleIdList></Reference><Reference><Citation>Curtis B.M., Scharnowske S., Watson A.J. Sequence and expression of a membrane-associated C-type lectin that exhibits CD4-independent binding of human immunodeficiency virus envelope glycoprotein gp120. Proc. Natl. Acad. Sci. USA. 1992;89:8356&#x2013;8360. doi: 10.1073/pnas.89.17.8356.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.89.17.8356</ArticleId><ArticleId IdType="pmc">PMC49917</ArticleId><ArticleId IdType="pubmed">1518869</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney K.B., Elliott J., Nassanian H., Song C., Soilleux E., McGowan I., Anton P.A., Lee B. Binding and transfer of human immunodeficiency virus by DC-SIGN+ cells in human rectal mucosa. J. Virol. 2005;79:5762&#x2013;5773. doi: 10.1128/JVI.79.9.5762-5773.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.9.5762-5773.2005</ArticleId><ArticleId IdType="pmc">PMC1082722</ArticleId><ArticleId IdType="pubmed">15827191</ArticleId></ArticleIdList></Reference><Reference><Citation>Granelli-Piperno A., Pritsker A., Pack M., Shimeliovich I., Arrighi J.F., Park C.G., Trumpfheller C., Piguet V., Moran T.M., Steinman R.M. Dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin/CD209 is abundant on macrophages in the normal human lymph node and is not required for dendritic cell stimulation of the mixed leukocyte reaction. J. Immunol. 2005;175:4265&#x2013;4273. doi: 10.4049/jimmunol.175.7.4265.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.175.7.4265</ArticleId><ArticleId IdType="pmc">PMC1378112</ArticleId><ArticleId IdType="pubmed">16177066</ArticleId></ArticleIdList></Reference><Reference><Citation>Rappocciolo G., Piazza P., Fuller C.L., Reinhart T.A., Watkins S.C., Rowe D.T., Jais M., Gupta P., Rinaldo C.R., Jr. Correction: DC-SIGN on B Lymphocytes Is Required for Transmission of HIV-1 to T Lymphocytes. PLoS Pathog. 2006;2:e88. doi: 10.1371/journal.ppat.0020088.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.0020088</ArticleId><ArticleId IdType="pmc">PMC1500807</ArticleId><ArticleId IdType="pubmed">16839201</ArticleId></ArticleIdList></Reference><Reference><Citation>Soilleux E.J., Morris L.S., Lee B., P&#xf6;hlmann S., Trowsdale J., Doms R.W., Coleman N. Placental expression of DC-SIGN may mediate intrauterine vertical transmission of HIV. J. Pathol. 2001;195:586&#x2013;592. doi: 10.1002/path.1026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.1026</ArticleId><ArticleId IdType="pubmed">11745695</ArticleId></ArticleIdList></Reference><Reference><Citation>Feinberg H., Guo Y., Mitchell D.A., Drickamer K., Weis W.I. Extended neck regions stabilize tetramers of the receptors DC-SIGN and DC-SIGNR. J. Biol. Chem. 2005;280:1327&#x2013;1335. doi: 10.1074/jbc.M409925200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M409925200</ArticleId><ArticleId IdType="pubmed">15509576</ArticleId></ArticleIdList></Reference><Reference><Citation>Koethe S., Avota E., Schneider-Schaulies S. Measles virus transmission from dendritic cells to T cells: Formation of synapse-like interfaces concentrating viral and cellular components. J. Virol. 2012;86:9773&#x2013;9781. doi: 10.1128/JVI.00458-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00458-12</ArticleId><ArticleId IdType="pmc">PMC3446594</ArticleId><ArticleId IdType="pubmed">22761368</ArticleId></ArticleIdList></Reference><Reference><Citation>Cormier E.G., Durso R.J., Tsamis F., Boussemart L., Manix C., Olson W.C., Gardner J.P., Dragic T. L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virus. Proc. Natl. Acad. Sci. USA. 2004;101:14067. doi: 10.1073/pnas.0405695101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0405695101</ArticleId><ArticleId IdType="pmc">PMC521122</ArticleId><ArticleId IdType="pubmed">15371595</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu L., KewalRamani V.N. Dendritic-cell interactions with HIV: Infection and viral dissemination. Nat. Rev. Immunol. 2006;6:859&#x2013;868. doi: 10.1038/nri1960.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri1960</ArticleId><ArticleId IdType="pmc">PMC1796806</ArticleId><ArticleId IdType="pubmed">17063186</ArticleId></ArticleIdList></Reference><Reference><Citation>Hajjar K.A., Acharya S.S. Annexin II and regulation of cell surface fibrinolysis. Ann. N. Y. Acad. Sci. 2000;902:265&#x2013;271. doi: 10.1111/j.1749-6632.2000.tb06321.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1749-6632.2000.tb06321.x</ArticleId><ArticleId IdType="pubmed">10865846</ArticleId></ArticleIdList></Reference><Reference><Citation>Grindheim A.K., Saraste J., Vedeler A. Protein phosphorylation and its role in the regulation of Annexin A2 function. Biochim. Biophys. Acta. 2017;1861:2515&#x2013;2529. doi: 10.1016/j.bbagen.2017.08.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbagen.2017.08.024</ArticleId><ArticleId IdType="pubmed">28867585</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao C., Zhang F., Kemp M.M., Linhardt R.J., Waisman D.M., Head J.F., Seaton B.A. Crystallographic analysis of calcium-dependent heparin binding to annexin A2. J. Biol. Chem. 2006;281:31689&#x2013;31695. doi: 10.1016/S0021-9258(19)84082-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(19)84082-6</ArticleId><ArticleId IdType="pmc">PMC4129640</ArticleId><ArticleId IdType="pubmed">16882661</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin M. Unique roles of tryptophanyl-tRNA synthetase in immune control and its therapeutic implications. Exp. Mol. Med. 2019;51:1&#x2013;10. doi: 10.1038/s12276-018-0196-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s12276-018-0196-9</ArticleId><ArticleId IdType="pmc">PMC6321835</ArticleId><ArticleId IdType="pubmed">30613102</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen N., Zhou M., Yang B., Yu Y., Dong X., Ding J. Catalytic mechanism of the tryptophan activation reaction revealed by crystal structures of human tryptophanyl-tRNA synthetase in different enzymatic states. Nucleic Acids Res. 2008;36:1288&#x2013;1299. doi: 10.1093/nar/gkm1153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkm1153</ArticleId><ArticleId IdType="pmc">PMC2275098</ArticleId><ArticleId IdType="pubmed">18180246</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldman R.D., Khuon S., Chou Y.H., Opal P., Steinert P.M. The function of intermediate filaments in cell shape and cytoskeletal integrity. J. Cell Biol. 1996;134:971&#x2013;983. doi: 10.1083/jcb.134.4.971.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.134.4.971</ArticleId><ArticleId IdType="pmc">PMC2120965</ArticleId><ArticleId IdType="pubmed">8769421</ArticleId></ArticleIdList></Reference><Reference><Citation>Das S., Ravi V., Desai A. Japanese encephalitis virus interacts with vimentin to facilitate its entry into porcine kidney cell line. Virus Res. 2011;160:404&#x2013;408. doi: 10.1016/j.virusres.2011.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2011.06.001</ArticleId><ArticleId IdType="pubmed">21798293</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J.K., Fahad A.M., Shanmukhappa K., Kapil S. Defining the cellular target(s) of porcine reproductive and respiratory syndrome virus blocking monoclonal antibody 7G10. J. Virol. 2006;80:689&#x2013;696. doi: 10.1128/JVI.80.2.689-696.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.80.2.689-696.2006</ArticleId><ArticleId IdType="pmc">PMC1346842</ArticleId><ArticleId IdType="pubmed">16378972</ArticleId></ArticleIdList></Reference><Reference><Citation>Koudelka K.J., Destito G., Plummer E.M., Trauger S.A., Siuzdak G., Manchester M. Endothelial targeting of cowpea mosaic virus (CPMV) via surface vimentin. PLoS Pathog. 2009;5:e1000417. doi: 10.1371/journal.ppat.1000417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000417</ArticleId><ArticleId IdType="pmc">PMC2670497</ArticleId><ArticleId IdType="pubmed">19412526</ArticleId></ArticleIdList></Reference><Reference><Citation>N&#xe9;dellec P., Vicart P., Laurent-Winter C., Martinat C., Pr&#xe9;vost M.C., Brahic M. Interaction of Theiler&#x2019;s virus with intermediate filaments of infected cells. J. Virol. 1998;72:9553&#x2013;9560. doi: 10.1128/JVI.72.12.9553-9560.1998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.72.12.9553-9560.1998</ArticleId><ArticleId IdType="pmc">PMC110461</ArticleId><ArticleId IdType="pubmed">9811688</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang A.H., Obiero J.M., Kulczyk A.W., Sviripa V.M., Tsodikov O.V. A crystal structure of coil 1B of vimentin in the filamentous form provides a model of a high-order assembly of a vimentin filament. FEBS J. 2018;285:2888&#x2013;2899. doi: 10.1111/febs.14585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.14585</ArticleId><ArticleId IdType="pmc">PMC8022333</ArticleId><ArticleId IdType="pubmed">29905014</ArticleId></ArticleIdList></Reference><Reference><Citation>Chowdhury I., Thompson W.E., Thomas K. Prohibitins role in cellular survival through Ras-Raf-MEK-ERK pathway. J. Cell. Physiol. 2014;229:998&#x2013;1004. doi: 10.1002/jcp.24531.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.24531</ArticleId><ArticleId IdType="pmc">PMC4413917</ArticleId><ArticleId IdType="pubmed">24347342</ArticleId></ArticleIdList></Reference><Reference><Citation>Su W., Huang S., Zhu H., Zhang B., Wu X. Interaction between PHB2 and Enterovirus A71 VP1 Induces Autophagy and Affects EV-A71 Infection. Viruses. 2020;12:414. doi: 10.3390/v12040414.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12040414</ArticleId><ArticleId IdType="pmc">PMC7232526</ArticleId><ArticleId IdType="pubmed">32276428</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshinaka T., Kosako H., Yoshizumi T., Furukawa R., Hirano Y., Kuge O., Tamada T., Koshiba T. Structural Basis of Mitochondrial Scaffolds by Prohibitin Complexes: Insight into a Role of the Coiled-Coil Region. iScience. 2019;19:1065&#x2013;1078. doi: 10.1016/j.isci.2019.08.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2019.08.056</ArticleId><ArticleId IdType="pmc">PMC6745515</ArticleId><ArticleId IdType="pubmed">31522117</ArticleId></ArticleIdList></Reference><Reference><Citation>Sako D., Chang X.J., Barone K.M., Vachino G., White H.M., Shaw G., Veldman G.M., Bean K.M., Ahern T.J., Furie B., et al. Expression cloning of a functional glycoprotein ligand for P-selectin. Cell. 1993;75:1179&#x2013;1186. doi: 10.1016/0092-8674(93)90327-M.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(93)90327-M</ArticleId><ArticleId IdType="pubmed">7505206</ArticleId></ArticleIdList></Reference><Reference><Citation>Laszik Z., Jansen P.J., Cummings R.D., Tedder T.F., McEver R.P., Moore K.L. P-selectin glycoprotein ligand-1 is broadly expressed in cells of myeloid, lymphoid, and dendritic lineage and in some nonhematopoietic cells. Blood. 1996;88:3010&#x2013;3021. doi: 10.1182/blood.V88.8.3010.bloodjournal8883010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.V88.8.3010.bloodjournal8883010</ArticleId><ArticleId IdType="pubmed">8874199</ArticleId></ArticleIdList></Reference><Reference><Citation>Somers W.S., Tang J., Shaw G.D., Camphausen R.T. Insights into the molecular basis of leukocyte tethering and rolling revealed by structures of P- and E-selectin bound to SLe(X) and PSGL-1. Cell. 2000;103:467&#x2013;479. doi: 10.1016/S0092-8674(00)00138-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(00)00138-0</ArticleId><ArticleId IdType="pubmed">11081633</ArticleId></ArticleIdList></Reference><Reference><Citation>Kjell&#xe9;n L., Lindahl U. Proteoglycans: Structures and interactions. Annu. Rev. Biochem. 1991;60:443&#x2013;475. doi: 10.1146/annurev.bi.60.070191.002303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.bi.60.070191.002303</ArticleId><ArticleId IdType="pubmed">1883201</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveh B., London N., Schueler-Furman O. Sub-angstrom modeling of complexes between flexible peptides and globular proteins. Proteins. 2010;78:2029&#x2013;2040. doi: 10.1002/prot.22716.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prot.22716</ArticleId><ArticleId IdType="pubmed">20455260</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T., Pan X., Chao L., Tan W., Qu S., Yang L., Wang B., Mei H. Subangstrom accuracy in pHLA-I modeling by Rosetta FlexPepDock refinement protocol. J. Chem. Inf. Model. 2014;54:2233&#x2013;2242. doi: 10.1021/ci500393h.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ci500393h</ArticleId><ArticleId IdType="pubmed">25050981</ArticleId></ArticleIdList></Reference><Reference><Citation>Waggoner S., Sarnow P. Viral ribonucleoprotein complex formation and nucleolar-cytoplasmic relocalization of nucleolin in poliovirus-infected cells. J. Virol. 1998;72:6699&#x2013;6709. doi: 10.1128/JVI.72.8.6699-6709.1998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.72.8.6699-6709.1998</ArticleId><ArticleId IdType="pmc">PMC109870</ArticleId><ArticleId IdType="pubmed">9658117</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen N., Guo L., Yang B., Jin Y., Ding J. Structure of human tryptophanyl-tRNA synthetase in complex with tRNATrp reveals the molecular basis of tRNA recognition and specificity. Nucleic Acids Res. 2006;34:3246&#x2013;3258. doi: 10.1093/nar/gkl441.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkl441</ArticleId><ArticleId IdType="pmc">PMC1538984</ArticleId><ArticleId IdType="pubmed">16798914</ArticleId></ArticleIdList></Reference><Reference><Citation>Ewing T.J., Makino S., Skillman A.G., Kuntz I.D. DOCK 4.0: Search strategies for automated molecular docking of flexible molecule databases. J. Comput. Aided Mol. Des. 2001;15:411&#x2013;428. doi: 10.1023/A:1011115820450.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1011115820450</ArticleId><ArticleId IdType="pubmed">11394736</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S.Y., Zou X. Ensemble docking of multiple protein structures: Considering protein structural variations in molecular docking. Proteins. 2007;66:399&#x2013;421. doi: 10.1002/prot.21214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prot.21214</ArticleId><ArticleId IdType="pubmed">17096427</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S.Y., Zou X. Efficient molecular docking of NMR structures: Application to HIV-1 protease. Protein Sci. 2007;16:43&#x2013;51. doi: 10.1110/ps.062501507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1110/ps.062501507</ArticleId><ArticleId IdType="pmc">PMC2222846</ArticleId><ArticleId IdType="pubmed">17123961</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S.Y., Zou X. An iterative knowledge-based scoring function for protein-protein recognition. Proteins. 2008;72:557&#x2013;579. doi: 10.1002/prot.21949.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prot.21949</ArticleId><ArticleId IdType="pubmed">18247354</ArticleId></ArticleIdList></Reference><Reference><Citation>Lalani S.S., Anasir M.I., Poh C.L. Antiviral activity of silymarin in comparison with baicalein against EV-A71. BMC Complement. Med. Ther. 2020;20:97. doi: 10.1186/s12906-020-2880-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12906-020-2880-2</ArticleId><ArticleId IdType="pmc">PMC7092479</ArticleId><ArticleId IdType="pubmed">32293397</ArticleId></ArticleIdList></Reference><Reference><Citation>Das S., Ott M., Yamane A., Tsai W., Gromeier M., Lahser F., Gupta S., Dasgupta A. A small yeast RNA blocks hepatitis C virus internal ribosome entry site (HCV IRES)-mediated translation and inhibits replication of a chimeric poliovirus under translational control of the HCV IRES element. J. Virol. 1998;72:5638&#x2013;5647. doi: 10.1128/JVI.72.7.5638-5647.1998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.72.7.5638-5647.1998</ArticleId><ArticleId IdType="pmc">PMC110227</ArticleId><ArticleId IdType="pubmed">9621022</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>